| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.94B | 48.83B | 46.43B | 41.37B | 36.90B | 34.82B |
| Gross Profit | 21.54B | 21.61B | 12.40B | 8.93B | 8.53B | 9.47B |
| EBITDA | 10.57B | 8.90B | 7.29B | 4.47B | 4.53B | 5.67B |
| Net Income | 7.60B | 6.29B | 5.00B | 2.99B | 2.84B | 3.66B |
Balance Sheet | ||||||
| Total Assets | 142.31B | 143.71B | 133.19B | 125.98B | 115.72B | 120.47B |
| Cash, Cash Equivalents and Short-Term Investments | 98.01B | 26.17B | 89.69B | 84.05B | 76.24B | 83.30B |
| Total Debt | 9.27B | 9.27B | 8.03B | 8.03B | 7.29B | 7.29B |
| Total Liabilities | 110.32B | 110.81B | 105.33B | 101.06B | 94.16B | 91.58B |
| Stockholders Equity | 31.99B | 32.89B | 27.86B | 24.92B | 21.56B | 28.89B |
Cash Flow | ||||||
| Free Cash Flow | 11.44B | 10.61B | 9.07B | 7.71B | 6.46B | 7.27B |
| Operating Cash Flow | 11.44B | 10.61B | 9.07B | 7.71B | 6.46B | 7.27B |
| Investing Cash Flow | -7.18B | -7.65B | -7.26B | -6.82B | -3.73B | -5.20B |
| Financing Cash Flow | -4.21B | -2.66B | -1.75B | -1.05B | -2.67B | -2.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $64.89B | 9.17 | 24.14% | 1.49% | 4.12% | 83.05% | |
82 Outperform | $55.93B | 5.29 | 39.47% | 1.91% | 4.40% | 209.62% | |
78 Outperform | $126.83B | 13.86 | 15.69% | 1.22% | 8.26% | 35.89% | |
76 Outperform | $26.06B | 12.62 | 26.08% | 1.88% | 6.60% | 9.14% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $22.18B | ― | 9.84% | ― | 2.96% | 1.82% | |
56 Neutral | $1.27B | 9.31 | 3.94% | ― | -4.55% | -4.02% |